Pesticides and Parkinson's disease - Is there a link?

Environmental Health Perspectives

Volumn 114, Issue 2, 2006, Pages 156-164

  Brown, Terry P ^a   Rumsby, Paul C ^b   Capleton, Alexander C ^a   Rushton, Lesley ^a   Levy, Leonard S ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b WRC PLC   (United Kingdom)

Author keywords

Epidemiology; Literature review; Parkinson's disease; Pesticides; Toxicology

Indexed keywords

DITHIOCARBAMIC ACID DERIVATIVE; HERBICIDE; INSECTICIDE; LEVODOPA; MANEB; ORGANOCHLORINE DERIVATIVE; PARAQUAT; PESTICIDE; PYRETHROID; ROTENONE;

CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LONG TERM EXPOSURE; METHODOLOGY; NEUROTOXICITY; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PUBLISHING; REVIEW; SCIENTIFIC LITERATURE;

ENVIRONMENTAL POLLUTANTS; EPIDEMIOLOGIC STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PARKINSON DISEASE; PESTICIDES; TOXICITY TESTS;

EID: 32044453150     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8095     Document Type: Review

References (121)

1. Adler CH. 1999. Differential diagnosis of Parkinson's disease. Med Clin North Am 83:349-367.
2. Alam M, Schmidt WJ. 2002. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136:317-324.
3. Ansari RA, Husain K, Gupta PK. 1987. Endosultan toxicity influence on biogenic amines of rat brain. J Environ Biol 8:229-236.
4. Bagetta G, Corasaniti MT, Iannone M, Nisticò G, Stephenson JD. 1992. Production of limbic motor seizures and brain damage by systemic and intracerebral injections of paraquat in rats. Pharmacol Toxicol 71:443-448.
5. Barlow BK, Thiruchelvam MJ, Bennice L, Cory-Slechta DA, Ballatori N, Richfield EK. 2003. Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates. J Neurochem 85:1075-1086.
6. Behari M, Srivastava AK, Des RR, Pandey RM. 2001. Risk factors of Parkinson's disease in Indian patients. J Neurol Sci 190:49-55.
7. Betarbet R, Sharer TB, Di Monte DA, Greenamyre JT. 2002. Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol 12:499-510.
8. Betarbet R, Sharer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306.
9. Bloomquist JR, Kirby ML, Castagnoli K, Miller GW. 1999. Effects of heptachlor exposure on neurochemical biomarkers of parkinsonism. In: Progress in Neuropharmacology and Neurotoxicology of Pesticides and Drugs (Beadle DJ, ed). Cambridge, UK:Royal Society of Chemistry, 195-203.
10. Butterfield PG, Valanis BG, Spencer PS, Lindeman CA, Nutt JG. 1993. Environmental antecedents of young-onset Parkinson's disease. Neurology 43:1150-1158.
11. Calò M, Iannone M, Passafaro M, Nisticò G. 1990. Selective vulnerability of hippocampal CA3 neurones after micro-infusion of paraquat into the rat substantia nigra or into the ventral tegmental area. J Comp Pathol 101:73-78.
12. Chan DKY, Woo J, Ho SC, Pang CP, Law LK, Ng PW, et al. 1998. Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 65:781-784.
13. Chaturvedi S, Østbye T, Stoessl AJ, Merskey H, Hachinski V. 1995. Environmental exposures in elderly Canadians with Parkinson's disease. Can J Neurol Sci 22:232-234.
14. Corasaniti MT, Bagetta G, Rodinò P, Gratteri S, Nisticò G. 1992. Neurotoxic effects induced by intracerebral and systemic injection of paraquat in rats. Hum Exp Toxicol 11:535-539.
15. Corasaniti MT, Strongoli MC, Rotiroti D, Bagetta G, Nisticò G. 1998. Paraquat: A useful tool for the in vivo study of mechanisms of neuronal cell death. Pharmacol Toxicol 83:1-7.
16. Corrigan FM, Murray L, Wyatt CL, Shore RF. 1998. Diortho-substituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp Neurol 150:339-342.
17. Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. 2000. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A 59:229-234.
18. Cory-Slechta DA, Thiruchelvam M, Barlow BK, Richfield EK. 2005. Developmental pesticide models of the Parkinson disease phenotype. Environ Health Perspect 113:1263-1270; doi:10.1289/ehp.7570 [Online 26 May 2005].
19. De Gori N, Froio F, Strongoli MC, De Francesco A, Calò M, Nisticò G. 1988. Behavioural and electrocortical changes induced by paraquat after injection in specific areas of the brain of the rat. Neuropharmacology 27:201-208.
20. de Rijk MC, Launer LJ, Berger K, Breteler MMB, Dartigues J-F, Baldereschi M, et al. 2000. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology 54(suppl 5):S21-S23.
21. Duzcan F, Zencir M, Ozdemir F, Cetin GO, Bagci H, Heutink P, et al. 2003. Familial influence on Parkinsonism in a rural area of Turkey (Kizilcaboluk-Denizli): a community-based case-control study. Mov Disord 18:799-804.
22. Engel LS, Seixas NS, Keifer MC, Longstreth WTJ, Checkoway H, 2001. Validity study of self-reported pesticide exposure among orchardists. J Expo Anal Environ Epidemiol 11:359-368.
23. Fahn S, Elton R. 1987. Unified Parkinson's disease rating scale. In: Recent Developments in Parkinson's Disease (Fahn S. Marsden CD, Goldstein M, Caine D, eds). Florham Park, NJ:Macmillan Healthcare Information, 153-163.
24. Fall P-A, Fredrikson M, Axelson O, Granérus A-K. 1999. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 14:28-37.
25. Falope ZF, Osuntokun BO, Ogunniyi A, 1992. Risk factors for Parkinson's disease in Nigerian Africans: a case-control study. J Trop Geograph Neurol 2:177-180.
26. Firestone JA, Smith-Weller T, Franklin G, Swanson P, Longstreth WT, Checkoway H. 2005. Pesticides and risk of Parkinson's disease. A population-based case-control study. Arch Neurol 62(1):91-95.
27. Fleming L, Mann JB, Bean J, Briggle T, Sanchez-Ramos JR. 1994. Parkinson's disease and brain levels of organochlorine pesticides. Ann Neurol 36:100-103.
28. Foltynie T, Sawcer S, Brayne C, Barker RA. 2002. The genetic basis of Parkinson's disease. J Neurol Neurosurg Psychiatry 73:363-370.
29. Fredriksson A, Fredriksson M, Eriksson P. 1993. Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice. Toxicol Appl Pharmacol 122:258-264.
30. Gao H-M, Hong J-S, Zhang W, Liu B. 2002. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 22:782-790.
31. Gao H-M, Hong J-S, Zhang W, Liu B. 2003. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci 23:1228-1236.
32. Golbe LI, Farrell TM, Davis PH. 1990. Follow-up study of early-life protective and risk factors in Parkinson's disease. Mov Disord 5:66-70.
33. Goldman SM, Tanner C. 1998. Etiology of Parkinson's disease. In: Parkinson's Disease and Movement Disorders (Jankovic J, Tolosa E, eds). London, UK:Williams and Wilkins, 133-158.
34. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. 1998. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50:1346-1350.
35. Herishanu YO, Medvedovski M, Goldsmith JR, Kordysh E. 2001. A case-control study of Parkinson's disease in urban population of southern Israel. Can J Neurol Sci 28:144-147.
36. Hernán MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. 2002. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52:276-284.
37. Hertzman C, Wiens M, Bowering D, Snow B, Calne D. 1990. Parkinson's disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 17:349-355.
38. Hertzman C, Wiens M, Snow B, Kelly S, Caine D. 1994. A case-control study of Parkinson's disease in a horticultural region of British Columbia. Mov Disord 9:69-75.
39. Ho SC, Woo J, Lee CM. 1989. Epidemiologic study of Parkinson's disease in Hong Kong. Neurology 39:1314-1318.
40. Hoehn MM, Yahr M. 1998. Parkinsonism: Onset, progression, and mortality. Neurology 39:1314-1318.
41. Hoppin JA, Yucel F, Dosemeci M, Sandler DP. 2002. Accuracy of self-reported pesticide use duration information from licensed pesticide applicators in the Agricultural Health Study. J Expo Anal Environ Epidemiol 12:313-318.
42. Hubble JP, Cao T, Hassanein RES, Neuberger JS, Koller WC. 1993. Risk factors for Parkinson's disease. Neurology 43:1693-1697.
43. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. 1992a, What features improve the accuracy of the clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 42:1142-1146.
44. Hughes AJ, Daniel SE, Kilford L, Lees AJ. 1992b. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184.
45. Husain R, Gupta A, Khanna VK, Seth PK. 1991. Neurotoxicological effects of a pyrethroid formulation, fenvalerate in rats. Res Commun Chem Pathol Pharmacol 73:111-114.
46. + into different areas of the rat brain. Acta Neurol 43:313-321.
47. Iannone M, Ciriolo MR, Rotilio G, Nistico G. 1991. Intra-nigral infusion of Cu-free superoxide dismutase prevents paraquat-induced behavioral stimulation and ECoG epileptogenic discharges in rats. Neuropharmacology 30:893-898.
48. Jiménez-Jiménez FJ, Mateo D, Giménez-Roldán S. 1992. Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area. Mov Disord 7:149-152.
49. Kamel F, Tanner CM, Hoppin JA, Umbach DM, Goldman SM, Aston DA, et al. 2001. Pilot study of Parkinson's disease (PD) in the agricultural health study (AHS). Neurotoxicology 22:883-884.
50. Karen DJ, Li W, Harp PR, Gillette JS, Bloomquist JR. 2001. Striatal dopaminergic pathways as a target for the insecticides permethrin and chlorpyrifos. Neurotoxicology 22:811-817.
51. Kirby ML, Barlow RL, Bloomquist JR. 2001. Neurotoxicity of the organochlorine insecticide heptachlor to murine striatal dopaminergic pathways. Toxicol Sci 61:100-106.
52. Kirby ML, Castagnoli K, Bloomquist JR. 1999. In vivo effects of deltamethrin on dopamine neurochemistry and the role of augmented neurotransmitter release. Pesticide Biochem Physiol 65:160-168.
53. Kirkey KL, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Gorell JM. 2001. Occupational categories at risk for Parkinson's disease. Am J Ind Med 39:564-571.
54. Kitazawa M, Anantharam V, Kanthasamy AG. 2001. Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic Biol Med 31:1473-1485.
55. Koller W, Vetere-Overfield B, Gray C, Alexander C, Chin T, Dolezal J, et al. 1990. Environmental risk factors in Parkinson's disease. Neurology 40:1218-1221.
56. Kuopio A-M, Marttila RJ, Helenius H, Rinne UK. 1999. Environmental risk factors in Parkinson's disease. Mov Disord 14:928-939.
57. Langston JW, Ballard PA, Tetrud JW, Irwin I. 1983. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980.
58. Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, et al. 1997. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48:1583-1588.
59. Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, et al. 1996. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46:922-930.
60. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. 2003. SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467-486.
61. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, et al. 1998. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 55:969-978.
62. Liu B, Hong J-S. 2003. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharm Exp Ther 304:1-7.
63. Malaviya M, Husain R, Seth PK, Husain R. 1993. Perinatal effects of two pyrethroid insecticides on brain neurotransmitter function in the neonatal rat. Vet Hum Toxicol 35:119-122.
64. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. 2002. The herbicide paraquat causes upregulation and aggregation of α-synuclein in mice. J Biol Chem 277:1641-1644.
65. McCann SJ, LeCouteur DG, Green AC, Brayne C, Johnson AG, Chan D, et al. 1998. The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology 17:310-317.
66. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Di Monte DA, Cory-Slechta DA, et al. 2002. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10:119-127.
67. McGrew DM, Irwin I, Langston JW. 2000. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice. Neurotoxicology 21:309-312.
68. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. 1998, Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 352:1344-1346.
69. Miller DB, Reinhard JF Jr, Daniels AJ, O'Callaghan JP. 1991. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium. J Neurochem 57:541-549.
70. Miller GW, Kirby ML, Levey AI, Bloomquist JR. 1999. Heptachlor alters expression and function of dopamine transporters. Neurotoxicology 20:631-637.
71. Morano A, Jiménez-Jiménez FJ, Molina JA, Antolin MA. 1994. Risk-factors for Parkinson's disease: case-control study in the province of Cáceres, Spain. Acta Neurol Scand 89:164-170.
72. Morato GS, Lemos T, Takahashi RN. 1989. Acute exposure to maneb alters some behavioral functions in the mouse. Neurotoxicol Teratol 11:421-425.
73. Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR, 1996. Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men. Neurology 46:1044-1050.
74. Naylor JL, Widdowson PS, Simpson MG, Farnworth M, Ellis MK, Lock EA. 1995. Further evidence that the blood/brain barrier impedes paraquat entry into the brain. Hum Exp Toxicol 14:587-594.
75. Nelson LM, Van den Eeden SK, Tanner CM, Efird JT, Bernstein AL. 2000, Home pesticide exposure and the risk of Parkinson's disease. Neurology 54:A472-A473.
76. Niehaus I, Lange JH. 2003. Endotoxin: Is it an environmental factor in the cause of Parkinson's disease? Occup Environ Med 60:378-382.
77. Paul V, Balasubramaniam E. 1997. Effects of single and repeated administration of endosulfan on behaviour and its interaction with centrally acting drugs in experimental animals: a mini review. Environ Toxicol Pharmacol 3:151-157.
78. Preux PM, Condet A, Anglade C, Druet-Cabanac M, Debrock C, Macharia W, et al. 2000. Parkinson's disease and environmental factors. Matched case-control study in the Limousin region, France. Neuroepidemiology 19:333-337.
79. Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. 2001. Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res 86:122-127.
80. Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. 2000. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology 21:435-440.
81. Purkerson-Parker S, McDaniel KL, Moser VC. 2001. Dopamine transporter binding in the rat striatum is increased by gestational, perinatal, and adolescent exposure to heptachlor. Toxicol Sci 64:216-223.
82. Sanchez-Ramos J, Facca A, Basit A, Song S. 1998. Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures. Exp Neurol 150:263-271.
83. Sanchez-Ramos JR, Hefti F, Weiner WJ. 1987. Paraquat and Parkinson's disease. Neurology 37:728.
84. Schapira AHV. 1999. Parkinson's disease. BMJ 318:311-314.
85. Schoenberg BS, Osuntokun BO, Adeuja AO, Bademosi O, Nottidge V, Anderson DW, et al. 1988. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 38:645-646.
86. Seidler A, Hellenbrand W, Robra B-P, Vieregge P, Nischan P, Joerg J, et al. 1996. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 46:1275-1284.
87. Semchuk KM, Love EJ. 1995. Effects of agricultural work and other proxy-derived case-control data on Parkinson's disease risk estimates. Am J Epidemiol 141:747-754.
88. Semchuk KM, Love EJ, Lee RG. 1992. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42:1328-1335.
89. Semchuk KM, Love EJ, Lee RG. 1993. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 43:1173-1180.
90. Seth PK, Saidi NF, Agrawal AK, Anand M. 1986. Neurotoxicity of endosulfan in young and adult rats. Neurotoxicology 7:623-635.
91. Sherer TB, Betarbet R, Greenamyre JT. 2002. Environment, mitochondria, and Parkinson's disease. Neuroscientist 8:192-197.
92. Shimizu K, Matsubara K, Ohtaki K, Fujimaru S, Saito O, Shiono H. 2003. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res 976:243-252.
93. Shimizu K, Ohtaki K, Matsubara K, Aoyama K, Uezono T, Saito O, et al. 2001. Carrier-mediated processes in blood - brain barrier penetration and neural uptake of paraquat. Brain Res 906:135-142.
94. Smargiassi A, Mutti A, De Rosa A, De Palma G, Negrotti A, Calzetti S. 1998. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. Neurotoxicology 19:709-712.
95. Soleo L, Defazio G, Scarselli R, Zefferino R, Livrea P, Foa V. 1996. Toxicity of fungicides containing ethylene-bis-dithiocarbamate in serumless dissociated mesencephalic-striatal primary coculture. Arch Toxicol 70:678-682.
96. Stedeford T, Cardozo-Pelaez F, Nemeth N, Song S, Harbison RD, Sanchez-Ramos J. 2001. Comparison of base-excision repair capacity in proliferating and differentiated PC 12 cells following acute challenge with dieldrin. Free Radic Biol Med 31:1272-1278.
97. Stern M, Dulaney E, Gruber SB, Golbe L, Bergen M, Hurtig H, et al. 1991. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. Arch Neurol 48:903-907.
98. Takahashi RN, Rogerio R, Zanin M. 1989. Maneb enhances MPTP neurotoxicity in mice. Res Commum Chem Pathol Pharmacol 66:167-170.
99. Tanner CM. 2003. Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies. Adv Neurol 91:133-142.
100. Tanner CM, Chen B, Wang W, Peng M, Liu Z, Liang X, et al. 1989. Environmental factors and Parkinson's disease: a case-control study in China. Neurology 39:660-664.
101. Tawara T, Fukushima T, Hojo N, Isobe A, Shiwaku K, Setogawa T, et al. 1996. Effects of paraquat on mitochondrial electron transport system and catecholamine contents in rat brain. Arch Toxicol 70:585-589.
102. Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, et al. 1999. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet 88:742-749.
103. Teitelbaum SL. 2002. Questionnaire assessment of nonoccupational pesticide exposure in epidemiologic studies of cancer. J Expo Anal Environ Epidemiol 12:373-380.
104. Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA. 2000a. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res 873:225-234.
105. Thiruchelvam M, McCormack A, Richfield EK, Beggs RB, Tank AW, Di Monte DA, et al. 2003. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur J Neurosci 18:589-600.
106. Thiruchelvam MJ, Powers JM, Cory-Slechta DA, Richfield EK. 2004. Risk factors for dopaminergic neuron loss in human α-synuclein transgenic mice. Eur J Neurosci 19:845-854.
107. Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA. 2000b. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J Neurosci 20:9207-9214.
108. Thiruchelvam M, Richfield EK, Goodman BM, Cory-Slechta DA, Baggs RB. 2002. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 22:872-873.
109. Twelves D, Pekins KSM, Counsell C. 2003. Systematic review of incidence studies of Parkinson's disease. Mov Disord 18:19-31.
110. Uversky VN, Li J, Bower K, Fink AL. 2002. Synergistic effects of pesticides and metals on the fibrillation of α-synuclein: implications for Parkinson's disease. Neurotoxicology 23:527-536.
111. Uversky VN, Li J, Fink AL 2001. Pesticides directly accelerate the rate of α-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett 500:105-108.
112. Vidal J-S, Elbaz A, Clavel J, Delemotte B, Alpérovitch A, Tzouri C. 2002. Exposure to pesticides and Parkinson's disease: a community-based case-control study among a population characterised by a high prevalence of exposure. Mov Disord 17(suppl 5):S80.
113. Wang F-L, Semchuk KM, Love EJ. 1994. Reliability of environmental and occupational exposure data provided by surrogate respondents in a case-control study of Parkinson's disease. J Clin Epidemiol 47:797-807
114. Wechsler LS, Checkoway H, Franklin GM, Costa LG. 1991. A pilot study of occupational and environmental risk factors or Parkinson's disease. Neurotoxicology 12:387-392.
115. Werneck AL, Alvarenga H. 1999. Genetics, drugs and environmental factors in Parkinson's disease. A case-control study. Arq Neuropsiquiatr 57:347-355.
116. Widdowson PS, Farnworth MJ, Simpson MG, Lock EA. 1996. Influence of age on the passage of paraquat through the blood-brain barrier in rats: a distribution and pathological examination. Hum Exp Toxicol 15:231-236.
117. Wong GF, Gray CS, Hassanein RS, Koller WC. 1991. Environmental risk factors in siblings with Parkinson's disease. Arch Neurol 48:287-289.
118. + toxicity? Proc West Pharmacol Soc 32:191-193.
119. Zayed J, Ducic S, Campanella O, Panisset JC, André P, Masson H, et al. 1990. Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci 17:286-291.
120. Zhang J, Fitsanakis VA, Gu G, Jing D, Ao M, Amarnath V, et al. 2003. Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J Neurochem 84:336-346.
121. Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R. 2002. Familial and environmental risk factors in Parkinson's disease: a case-control study in north-east Italy. Acta Neurol Scand 105:77-82.